What Is Artificial Intelligence, Really – and What Is It Not?

Every conversation I have in a pharmaceutical plant starts the same way: someone uses the word “AI” to describe five completely different things – a rules-based alarm, a statistical dashboard, a vision system, a chatbot, and a Hollywood robot. Before deciding whether AI can help your operations, we need to agree on what we’re talking about.

At its core, Artificial Intelligence is software that performs tasks which, when done by humans, require perception, judgment, or learning – recognizing a defect on a vial, predicting when a motor will fail, extracting meaning from a maintenance report. The key distinction from traditional software is this: traditional software follows rules written by a programmer; AI learns patterns from data.

A rules-based system says: “If temperature exceeds 80°C, raise an alarm.” Someone wrote that rule. An AI system, instead, is shown thousands of examples of normal and abnormal behavior and learns, on its own, what “abnormal” looks like – including combinations no engineer would have thought to encode.

What AI is not: it is not conscious, it does not “understand” in the human sense, and it is not infallible. It is a statistical machine that generalizes from examples. This has a crucial consequence for regulated industries: an AI system is only as good as the data it learned from, and it can fail in ways rule-based systems never do – confidently and silently.

In pharma and traceability, this distinction matters daily. Your serialization system enforcing an aggregation hierarchy is rules. A vision model learning to distinguish a cosmetic scratch from a critical crack is AI. Both are valuable; they must be governed differently.

My advice: ban the generic word “AI” from your internal meetings. Force everyone to say what kind of system they mean. Half of your alignment problems will disappear immediately.